CIK 0001515673
- Large accelerated filer
Ultragenyx Pharmaceutical Inc.
Sign in to watch- Ticker
- RARE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 272546083
- Phone
- +1 415-483-8800
- Business address
- 60 LEVERONI COURT, NOVATO, CA, 94949
- 4 Open-market sale EVP and Chief Medical Officer sold 2,821 shares at $66.62 ($187,935)
- 4 Shares withheld for taxes President & CEO gave up 12,162 shares (to pay taxes)
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 4 Open-market sale EVP and Chief Medical Officer sold 1,657 shares at $66.30 ($109,859)
- 4 Open-market sale EVP and Chief Medical Officer sold 359 shares at $81.14 ($29,129)
- 4 Open-market sale EVP & Chief Commercial Officer sold 303 shares at $81.14 ($24,585)
- 4 Open-market sale EVP & Chief Tech Ops Officer sold 358 shares at $81.14 ($29,048)
- 4 Open-market sale SVP, Chief Accounting Officer sold 140 shares at $81.14 ($11,360)
- 4 Open-market sale CBO & EVP sold 286 shares at $81.14 ($23,206)
- 4 Open-market sale EVP and General Counsel sold 310 shares at $81.14 ($25,153)
- 4 Shares withheld for taxes President & CEO gave up 853 shares (to pay taxes)
- 4 Open-market sale Pinion John Richard sold 358 shares at $81.14 ($29,048)
- 4 Open-market sale CFO & Executive Vice President sold 6,738 shares at an average $82.00 ($552,524)
- 4 Exercise or conversion CBO & EVP acquired 109,734 shares (option exercise)
- 4 Open-market sale EVP and General Counsel sold 7,336 shares at $100.65 ($738,368)
- 4 Open-market sale EVP and Chief Medical Officer sold 5,000 shares at an average $100.11 ($500,525)
- 4 Open-market sale Director sold 800,000 shares at an average $54.54 ($43,631,250)
- 4 Open-market sale EVP & Chief Commercial Officer sold 375 shares at $91.53 ($34,324)
- 4 Grant or award Director acquired 3,895 shares (grant or award)
Page 9 of 32 · 627 filings